These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8076767)

  • 1. Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis.
    Treichel U; McFarlane BM; Seki T; Krawitt EL; Alessi N; Stickel F; McFarlane IG; Kiyosawa K; Furuta S; Freni MA
    Gastroenterology; 1994 Sep; 107(3):799-804. PubMed ID: 8076767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis.
    Treichel U; Poralla T; Hess G; Manns M; Meyer zum Büschenfelde KH
    Hepatology; 1990 Apr; 11(4):606-12. PubMed ID: 1691732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis.
    Treichel U; Gerken G; Rossol S; Rotthauwe HW; Meyer zum Büschenfelde KH; Poralla T
    J Hepatol; 1993 Aug; 19(1):55-63. PubMed ID: 8301043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-asialoglycoprotein receptor autoantibodies, detected by a capture-immunoassay, are associated with autoimmune liver diseases.
    Yoshioka M; Mizuno M; Morisue Y; Shimada M; Hirai M; Nasu J; Okada H; Sakaguchi K; Yamamoto K; Tsuji T
    Acta Med Okayama; 2002 Apr; 56(2):99-105. PubMed ID: 12002624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-induced anti-asialoglycoprotein receptor autoimmunity in experimental hepadnaviral hepatitis.
    Diao J; Michalak TI
    Hepatology; 1997 Mar; 25(3):689-96. PubMed ID: 9049220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA--revival of a disease-activity marker in autoimmune hepatitis.
    Hausdorf G; Roggenbuck D; Feist E; Büttner T; Jungblut PR; Conrad K; Berg C; Klein R
    Clin Chim Acta; 2009 Oct; 408(1-2):19-24. PubMed ID: 19576873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro.
    Löhr H; Treichel U; Poralla T; Manns M; Meyer zum Büschenfelde KH
    Clin Exp Immunol; 1992 Apr; 88(1):45-9. PubMed ID: 1532926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases.
    Villalta D; Mytilinaiou MG; Elsner M; Hentschel C; Cuccato J; Somma V; Schierack P; Roggenbuck D; Bogdanos DP
    Clin Chim Acta; 2015 Oct; 450():1-5. PubMed ID: 26220739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Diagnostic Value of Autoantibodies to Asialoglycoprotein Receptor Combined with Antinuclear Antibody in Autoimmune Hepatitis.
    Zhuang Z; Li K; Yu Y
    Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to asialoglycoprotein receptor in chronic hepatitis C patients.
    Husa P; Chalupa P; Stroblová H; Husová L; Slesinger P; Zajíc J
    Acta Virol; 2001 Feb; 45(1):7-11. PubMed ID: 11394582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-mediated cytotoxicity and inhibition of ligand binding to hepatocytes by woodchuck hepatitis virus-induced autoantibodies to asialoglycoprotein receptor.
    Diao J; Churchill ND; Michalak TI
    Hepatology; 1998 Jun; 27(6):1623-31. PubMed ID: 9620336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of circulating autoantibodies directed against the asialoglycoprotein receptor using recombinant receptor subunit H1.
    Schreiter T; Liu C; Gerken G; Treichel U
    J Immunol Methods; 2005 Jun; 301(1-2):1-10. PubMed ID: 15890353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers.
    Treichel U; Meyer zum Büschenfelde KH; Stockert RJ; Poralla T; Gerken G
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3021-9. PubMed ID: 7964611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human asialoglycoprotein receptor as an autoantigen in chronic hepatitis.
    Meyer zum Büschenfelde KH; Treichel U; Löhr H; Fleischer B; Poralla T
    Immunol Res; 1991; 10(3-4):497-502. PubMed ID: 1955777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found.
    Rigopoulou EI; Roggenbuck D; Smyk DS; Liaskos C; Mytilinaiou MG; Feist E; Conrad K; Bogdanos DP
    Autoimmun Rev; 2012 Dec; 12(2):260-9. PubMed ID: 22571878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auto-antibodies to the asialoglycoprotein receptor in sera of children with auto-immune hepatitis.
    Hajoui O; Debray D; Martin S; Alvarez F
    Eur J Pediatr; 2000 May; 159(5):310-3. PubMed ID: 10834513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States.
    Czaja AJ; Carpenter HA; Santrach PJ; Moore SB; Taswell HF; Homburger HA
    J Hepatol; 1993 Jul; 18(3):342-52. PubMed ID: 8228128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.